S&P 500   3,376.29 (+1.28%)
DOW   27,896.34 (+0.76%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,376.29 (+1.28%)
DOW   27,896.34 (+0.76%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,376.29 (+1.28%)
DOW   27,896.34 (+0.76%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,376.29 (+1.28%)
DOW   27,896.34 (+0.76%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
Log in

NYSE:LHLaboratory Corp. of America Stock Price, Forecast & News

$187.93
+1.80 (+0.97 %)
(As of 08/12/2020 01:39 PM ET)
Add
Compare
Today's Range
$185.65
Now: $187.93
$188.79
50-Day Range
$157.09
MA: $182.60
$201.30
52-Week Range
$98.02
Now: $187.93
$206.74
Volume15,379 shs
Average Volume981,415 shs
Market Capitalization$18.30 billion
P/E Ratio51.21
Dividend YieldN/A
Beta1.41
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and medical drug monitoring; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, it provides technology-enabled solutions, including a suite of applications to enable patients, healthcare providers, health systems, accountable care organizations, and insurers with convenient and secure access to LCD's data and services, as well as billing for laboratory services. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, academic institutions, and independent clinical laboratories. Laboratory Corporation of America Holdings has collaborations with the Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, Yale University, and QIAGEN N.V. The company was founded in 1971 and is headquartered in Burlington, North Carolina.
Read More
Laboratory Corp. of America logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.49 out of 5 stars


Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
CUSIP50540R40
Phone336-229-1127

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.55 billion
Cash Flow$18.93 per share
Book Value$77.93 per share

Profitability

Net Income$823.80 million

Miscellaneous

Employees65,000
Market Cap$18.30 billion
Next Earnings Date10/22/2020 (Estimated)
OptionableOptionable
$187.93
+1.80 (+0.97 %)
(As of 08/12/2020 01:39 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Laboratory Corp. of America (NYSE:LH) Frequently Asked Questions

How has Laboratory Corp. of America's stock been impacted by COVID-19 (Coronavirus)?

Laboratory Corp. of America's stock was trading at $158.99 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, LH stock has increased by 18.2% and is now trading at $187.93.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Laboratory Corp. of America?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratory Corp. of America in the last year. There are currently 2 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Laboratory Corp. of America
.

When is Laboratory Corp. of America's next earnings date?

Laboratory Corp. of America is scheduled to release its next quarterly earnings announcement on Thursday, October 22nd 2020.
View our earnings forecast for Laboratory Corp. of America
.

How were Laboratory Corp. of America's earnings last quarter?

Laboratory Corp. of America Holdings (NYSE:LH) announced its earnings results on Tuesday, July, 28th. The medical research company reported $2.57 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.78 by $1.79. The medical research company earned $2.77 billion during the quarter, compared to analyst estimates of $2.44 billion. Laboratory Corp. of America had a net margin of 3.16% and a return on equity of 14.39%. Laboratory Corp. of America's revenue was down 3.9% compared to the same quarter last year. During the same period in the previous year, the business posted $2.93 earnings per share.
View Laboratory Corp. of America's earnings history
.

What price target have analysts set for LH?

16 equities research analysts have issued 12 month price targets for Laboratory Corp. of America's shares. Their forecasts range from $170.00 to $249.00. On average, they anticipate Laboratory Corp. of America's stock price to reach $214.94 in the next year. This suggests a possible upside of 14.4% from the stock's current price.
View analysts' price targets for Laboratory Corp. of America
.

Has Laboratory Corp. of America been receiving favorable news coverage?

Media stories about LH stock have been trending negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Laboratory Corp. of America earned a media sentiment score of -2.2 on InfoTrie's scale. They also gave news coverage about the medical research company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days.
View the latest news about Laboratory Corp. of America
.

Who are some of Laboratory Corp. of America's key competitors?

What other stocks do shareholders of Laboratory Corp. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Corp. of America investors own include Gilead Sciences (GILD), Micron Technology (MU), Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Johnson & Johnson (JNJ), AbbVie (ABBV), Amgen (AMGN), Alibaba Group (BABA) and Abbott Laboratories (ABT).

Who are Laboratory Corp. of America's key executives?

Laboratory Corp. of America's management team includes the following people:
  • Mr. David P. King, Chairman, CEO & Pres (Age 63)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 58)
  • Mr. F. Samuel Eberts III, Chief Legal Officer, Chief Compliance Officer, Sr. VP & Sec. (Age 59)
  • Mr. John D. Ratliff, Chief Exec. Officer of Covance Drug Devel. (Age 59)
  • Dr. Michelle Abelson, Laboratory Director of Operations

What is Laboratory Corp. of America's stock symbol?

Laboratory Corp. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

Who are Laboratory Corp. of America's major shareholders?

Laboratory Corp. of America's stock is owned by many different retail and institutional investors. Top institutional investors include Allen Investment Management LLC (1.27%), California Public Employees Retirement System (0.84%), Bessemer Group Inc. (0.83%), Veritas Investment Management LLP (0.72%), New York State Common Retirement Fund (0.68%) and Sumitomo Mitsui Trust Holdings Inc. (0.64%). Company insiders that own Laboratory Corp. of America stock include David P King, Der Vaart Sandra D Van, Glenn A Eisenberg, Jean-Luc Belingard, Judith C Seltz, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, Mark S Schroeder, Peter J Wilkinson, R Sanders Williams and Robert E Mittelstaedt Jr.
View institutional ownership trends for Laboratory Corp. of America
.

Which institutional investors are selling Laboratory Corp. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including Thompson Siegel & Walmsley LLC, Calamos Advisors LLC, Assenagon Asset Management S.A., Teacher Retirement System of Texas, Weitz Investment Management Inc., First Trust Advisors LP, Kornitzer Capital Management Inc. KS, and State of Alaska Department of Revenue. Company insiders that have sold Laboratory Corp. of America company stock in the last year include David P King, Der Vaart Sandra D Van, Jean-Luc Belingard, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, Mark S Schroeder, Peter J Wilkinson, and R Sanders Williams.
View insider buying and selling activity for Laboratory Corp. of America
.

Which institutional investors are buying Laboratory Corp. of America stock?

LH stock was acquired by a variety of institutional investors in the last quarter, including Hunter Perkins Capital Management LLC, Bessemer Group Inc., Veritas Investment Management LLP, Bank of Nova Scotia, Candriam Luxembourg S.C.A., First Eagle Investment Management LLC, MERIAN GLOBAL INVESTORS UK Ltd, and Davidson Investment Advisors.
View insider buying and selling activity for Laboratory Corp. of America
.

How do I buy shares of Laboratory Corp. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Laboratory Corp. of America's stock price today?

One share of LH stock can currently be purchased for approximately $187.93.

How big of a company is Laboratory Corp. of America?

Laboratory Corp. of America has a market capitalization of $18.30 billion and generates $11.55 billion in revenue each year. The medical research company earns $823.80 million in net income (profit) each year or $11.32 on an earnings per share basis. Laboratory Corp. of America employs 65,000 workers across the globe.

What is Laboratory Corp. of America's official website?

The official website for Laboratory Corp. of America is www.labcorp.com.

How can I contact Laboratory Corp. of America?

Laboratory Corp. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.